A double-blind, placebo-controlled, parallel study to evaluate the effects of GW856553 on endothelial function/vascular compliance in subjects with dyslipidaemia.
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2012
At a glance
- Drugs Losmapimod (Primary)
- Indications Dyslipidaemias; Lipid metabolism disorders
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 15 Oct 2008 Actual start date changed from May 2007 to July 2007 as reported by Clinicaltrials.gov.
- 12 Oct 2008 Trial phase changed from I/II to II as reported by ClinicalTrials.gov.